Stockreport

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com
PDF Full Year 2025 LUPKYNIS Sales Grew 25%Announces LUPKYNIS Sales Guidance for 2026 of $305 Million to $315 Million ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- [Read more]